ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS
November 17, 2020Catalent Pharma Solutions has completed the acquisition of Bone Therapeutics’ manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), announced on 29 October 2020. -
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility
October 30, 2020Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), including all of its assets located in Gosselies, Belgium.
Pharma Sources Insight January 2025
